XML 49 R59.htm IDEA: XBRL DOCUMENT v3.3.0.814
Pro Forma Information – Viro Acquisition (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Net sales $ 1,709 $ 1,969 $ 5,104 $ 5,832
Earnings from continuing operations attributable to the Company $ 25 $ 68 $ 164 $ 308
Diluted earnings per share from continuing operations $ 0.15 $ 0.41 $ 1.01 $ 1.85
As Reported        
Net sales $ 1,566 $ 1,745 $ 4,530 $ 5,181
Earnings from continuing operations attributable to the Company $ 18 $ 61 $ 131 $ 297
Diluted earnings per share from continuing operations $ 0.11 $ 0.37 $ 0.81 $ 1.79
Vitro F&B Adjustments        
Net sales $ 143 $ 224 $ 574 $ 651
Earnings from continuing operations attributable to the Company 18 25 79 64
Financing Adjustments        
Earnings from continuing operations attributable to the Company $ (11) $ (18) $ (46) $ (53)